Project Grant HT94252410474
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The Defense Health Agency awarded Duke University a $1,255,621 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop diagnostic and therapeutic agents targeting Borrelia burgdorferi, the causative agent of Lyme disease. The grant, with a performance period from September 15, 2024 to September 14, 2027, will enable Duke to conduct innovative biomedical research aimed at improving health outcomes for military service members and the broader public. As a...
The U.S. Defense Health Agency awarded a $1,161,428 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of a "Fully Automated, Multimodal, and Multiplexed Ferrobotic System for Point-of-Care Pathogenic and Serological Tick-Borne Disease Diagnosis." This advanced biomedical research project aims to transform healthcare for military...
This federal Project Grant award of $1,176,645.00, granted by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the development of a highly accurate proteomic diagnostic assay to identify active Borreliosis (Lyme disease) infection with point-of-need collection technology. The grant recipient, George Mason University, will conduct this research in collaboration with a subcontract to The Johns Hopkins University, which will provide...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The University of California, Los Angeles (UCLA) was awarded a $739,332 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 1, 2025, supports a 3-year research project to develop a machine learning approach using patient registry data to reveal the neurological manifestations of persistent Lyme disease. The research aims to transform healthcare for military service members, veterans, and the broader public...
The University of Maryland, College Park was awarded a $1,292,721.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2025, supports the development of "Novel Small-Molecule Therapeutics Against Lyme Disease" over a project period ending on September 29, 2028. This research effort aims to transform healthcare for military service members, veterans, and the public...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
The Department of the Army Medical Command awarded $754,214 to The Research Foundation for the State University of New York at Stony Brook University under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2022 to August 31, 2025. The project aims to develop peripheral blood biomarkers to diagnose active Lyme disease and post-treatment Lyme disease syndrome. Stony Brook University will investigate medical solutions for Lyme disease diagnosis through innovative...